Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse.

Kumar A, Sha F, Toure A, Dogan A, Ni A, Batlevi CL, Palomba MLM, Portlock C, Straus DJ, Noy A, Horwitz SM, Moskowitz A, Hamlin P, Moskowitz CH, Matasar MJ, Zelenetz AD, Younes A.

Blood Cancer J. 2019 May 20;9(6):50. doi: 10.1038/s41408-019-0209-5.

PMID:
31110172
2.

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.

Soumerai JD, Ni A, Darif M, Londhe A, Xing G, Mun Y, Kay NE, Shanafelt TD, Rabe KG, Byrd JC, Chanan-Khan AA, Furman RR, Hillmen P, Jones J, Seymour JF, Sharman JP, Ferrante L, Mobasher M, Stark T, Reddy V, Dreiling LK, Bhargava P, Howes A, James DF, Zelenetz AD.

Lancet Haematol. 2019 May 17. pii: S2352-3026(19)30085-7. doi: 10.1016/S2352-3026(19)30085-7. [Epub ahead of print]

PMID:
31109827
3.

Neuronal effects of spatial and feature attention differ due to normalization.

Ni AM, Maunsell JHR.

J Neurosci. 2019 May 8. pii: 2106-18. doi: 10.1523/JNEUROSCI.2106-18.2019. [Epub ahead of print]

PMID:
31068439
4.

Alterations of Hematologic and Hematopoietic Parameters in Mice Exposed to Pulsed Electromagnetic Field.

Li K, Teng Z, Liu Z, Zhang Y, Long K, Liao Q, Ni A, Ding G, Ma S.

J Immunol Res. 2019 Mar 24;2019:3628956. doi: 10.1155/2019/3628956. eCollection 2019.

5.

Harnessing Clinical Sequencing Data for Survival Stratification of Patients with Metastatic Lung Adenocarcinomas.

Shen R, Martin A, Ni A, Hellmann M, Arbour KC, Jordan E, Arora A, Ptashkin R, Zehir A, Kris MG, Rudin CM, Berger MF, Solit DB, Seshan VE, Arcila M, Ladanyi M, Riely GJ.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00307. Epub 2019 Mar 28.

6.

Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers.

Drilon A, Schoenfeld AJ, Arbour KC, Litvak A, Ni A, Montecalvo J, Yu HA, Panora E, Ahn L, Kennedy M, Haughney-Siller A, Miller V, Ginsberg M, Ladanyi M, Arcila M, Rekhtman N, Kris MG, Riely GJ.

Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). pii: a003665. doi: 10.1101/mcs.a003665. Print 2019 Apr.

7.

Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.

Rekhtman N, Desmeules P, Litvak AM, Pietanza MC, Santos-Zabala ML, Ni A, Montecalvo J, Chang JC, Beras A, Preeshagul IR, Sabari JK, Rudin CM, Ladanyi M, Klimstra DS, Travis WD, Lai WC.

Mod Pathol. 2019 Mar 28. doi: 10.1038/s41379-019-0248-2. [Epub ahead of print]

PMID:
30923345
8.

Pretumor microenvironment of hepatocellular carcinoma: Cancerization or anticancerization?

Li G, Ni A, Yu M.

Gene. 2019 Jun 15;701:46-54. doi: 10.1016/j.gene.2019.03.034. Epub 2019 Mar 20.

PMID:
30902783
9.

Quality of life improves after palliative placement of percutaneous tunneled drainage catheter for refractory ascites in prospective study of patients with end-stage cancer.

Robson PC, Gonen M, Ni A, Brody L, Brown KT, Getrajdman G, Thom B, Kline N, Covey A.

Palliat Support Care. 2019 Mar 18:1-9. doi: 10.1017/S1478951519000051. [Epub ahead of print]

PMID:
30880658
10.

Role of imaging in low grade cutaneous B-cell lymphoma presenting in the skin.

Kheterpal MK, Dai J, Geller S, Pulitzer M, Ni A, Myskowski PL, Moskowitz A, Kim J, Hong EK, Fong S, Hoppe RT, Kim YH, Horwitz SM.

J Am Acad Dermatol. 2019 Jan 28. pii: S0190-9622(19)30144-6. doi: 10.1016/j.jaad.2019.01.037. [Epub ahead of print]

PMID:
30703460
11.

Quantum Yields and N2O Formation from Photolysis of Solid Films of Neonicotinoids.

Wang W, Aregahegn KZ, Andersen ST, Ni AZ, Rohrbacher AF, Nielsen OJ, Finlayson-Pitts BJ.

J Agric Food Chem. 2019 Feb 13;67(6):1638-1646. doi: 10.1021/acs.jafc.8b05417. Epub 2019 Jan 30.

PMID:
30698961
12.

Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study.

Lai WV, Lebas L, Barnes TA, Milia J, Ni A, Gautschi O, Peters S, Ferrara R, Plodkowski AJ, Kavanagh J, Sabari JK, Clarke SJ, Pavlakis N, Drilon A, Rudin CM, Arcila ME, Leighl NB, Shepherd FA, Kris MG, Mazières J, Li BT.

Eur J Cancer. 2019 Mar;109:28-35. doi: 10.1016/j.ejca.2018.11.030. Epub 2019 Jan 24.

PMID:
30685684
13.

Process-Induced Stress and Deformation of Variable-Stiffness Composite Cylinders during Curing.

Zhang G, Wang J, Ni A.

Materials (Basel). 2019 Jan 14;12(2). pii: E259. doi: 10.3390/ma12020259.

14.

A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers.

Sabari JK, Offin M, Stephens D, Ni A, Lee A, Pavlakis N, Clarke S, Diakos CI, Datta S, Tandon N, Martinez A, Myers ML, Makhnin A, Leger Y, Yu HA, Paik PK, Chaft JE, Kris MG, Jeon JO, Borsu LA, Ladanyi M, Arcila ME, Hernandez J, Henderson S, Shaffer T, Garg K, DiPasquo D, Raymond CK, Lim LP, Li M, Hellmann MD, Drilon A, Riely GJ, Rusch VW, Jones DR, Rimner A, Rudin CM, Isbell JM, Li BT.

J Natl Cancer Inst. 2018 Nov 28. doi: 10.1093/jnci/djy156. [Epub ahead of print]

PMID:
30496436
15.

Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy.

Ito K, Schöder H, Teng R, Humm JL, Ni A, Wolchok JD, Weber WA.

Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):930-939. doi: 10.1007/s00259-018-4211-0. Epub 2018 Nov 28.

PMID:
30488098
16.

Layered Hybrid Zincophosphites for Room Temperature Phosphorescent Emission.

Mu Y, Ni AY, Han SD, Pan J, Li JH, Wang GM.

Inorg Chem. 2018 Dec 3;57(23):14497-14500. doi: 10.1021/acs.inorgchem.8b02792. Epub 2018 Nov 12.

PMID:
30417646
17.

18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma.

Ito K, Teng R, Schöder H, Humm JL, Ni A, Michaud L, Nakajima R, Yamashita R, Wolchok JD, Weber WA.

J Nucl Med. 2019 Mar;60(3):335-341. doi: 10.2967/jnumed.118.213652. Epub 2018 Nov 9.

PMID:
30413661
18.

Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials.

Soumerai JD, Ni A, Xing G, Huang J, Furman RR, Jones J, Sharman JP, Hallek M, Adewoye AH, Dubowy R, Dreiling L, Zelenetz AD.

Leuk Lymphoma. 2018 Nov 8:1-9. doi: 10.1080/10428194.2018.1540782. [Epub ahead of print]

PMID:
30407886
19.

Electrical Microstimulation of Visual Cerebral Cortex Elevates Psychophysical Detection Thresholds.

Cone JJ, Ni AM, Ghose K, Maunsell JHR.

eNeuro. 2018 Oct 30;5(5). pii: ENEURO.0311-18.2018. doi: 10.1523/ENEURO.0311-18.2018. eCollection 2018 Sep-Oct.

20.

A retrospective seroepidemiologic survey of Chlamydia pneumoniae infection in patients in Beijing between 2008 and 2017.

Cui J, Yan W, Xie H, Xu S, Wang Q, Zhang W, Ni A.

PLoS One. 2018 Nov 7;13(11):e0206995. doi: 10.1371/journal.pone.0206995. eCollection 2018.

21.

Landscape of PD-1/PD-L1 Regulation and Targeted Immunotherapy.

Ni JM, Ni AP.

Chin Med Sci J. 2018 Sep 20;33(3):174-182. doi: 10.24920/21804.

PMID:
30266108
22.

Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.

Dunn LA, Sherman EJ, Baxi SS, Tchekmedyian V, Grewal RK, Larson SM, Pentlow KS, Haque S, Tuttle RM, Sabra MM, Fish S, Boucai L, Walters J, Ghossein RA, Seshan VE, Ni A, Li D, Knauf JA, Pfister DG, Fagin JA, Ho AL.

J Clin Endocrinol Metab. 2019 May 1;104(5):1417-1428. doi: 10.1210/jc.2018-01478.

PMID:
30256977
23.

Identification and differential expression of microRNAs in the testis of chicken with high and low sperm motility.

Liu Y, Sun Y, Li Y, Bai H, Xu S, Xu H, Ni A, Yang N, Chen J.

Theriogenology. 2018 Dec;122:94-101. doi: 10.1016/j.theriogenology.2018.09.010. Epub 2018 Sep 13.

PMID:
30243140
24.

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.

Sabari JK, Leonardi GC, Shu CA, Umeton R, Montecalvo J, Ni A, Chen R, Dienstag J, Mrad C, Bergagnini I, Lai WV, Offin M, Arbour KC, Plodkowski AJ, Halpenny DF, Paik PK, Li BT, Riely GJ, Kris MG, Rudin CM, Sholl LM, Nishino M, Hellmann MD, Rekhtman N, Awad MM, Drilon A.

Ann Oncol. 2018 Oct 1;29(10):2085-2091. doi: 10.1093/annonc/mdy334.

PMID:
30165371
25.

The associations between anthropometric measurements and left ventricular structure and function: the Echo-SOL Study.

Ponce S, Allison MA, Swett K, Cai J, Desai AA, Hurwitz BE, Ni A, Schneiderman N, Shah SJ, Spevack DM, Talavera GA, Rodriguez CJ.

Obes Sci Pract. 2018 Jun 14;4(4):387-395. doi: 10.1002/osp4.279. eCollection 2018 Aug.

26.

Tuning Parameter Selection in Cox Proportional Hazards Model with a Diverging Number of Parameters.

Ni A, Cai J.

Scand Stat Theory Appl. 2018 Sep;45(3):557-570. doi: 10.1111/sjos.12313. Epub 2018 Jan 16.

PMID:
30147217
27.

Inhibition of Noncanonical Murine Double Minute 2 Homolog Abrogates Ocular Inflammation through NF-κB Suppression.

Fan Y, Zhang W, Ni A, Mahato B, Chavala SH.

Am J Pathol. 2018 Sep;188(9):2087-2096. doi: 10.1016/j.ajpath.2018.05.017. Epub 2018 Jul 3.

PMID:
30126549
28.

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai WV, Hendriks LEL, Sabari JK, Caramella C, Plodkowski AJ, Halpenny D, Chaft JE, Planchard D, Riely GJ, Besse B, Hellmann MD.

J Clin Oncol. 2018 Oct 1;36(28):2872-2878. doi: 10.1200/JCO.2018.79.0006. Epub 2018 Aug 20.

PMID:
30125216
29.

Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers.

Offin M, Rizvi H, Tenet M, Ni A, Sanchez-Vega F, Li BT, Drilon A, Kris MG, Rudin CM, Schultz N, Arcila ME, Ladanyi M, Riely GJ, Yu H, Hellmann MD.

Clin Cancer Res. 2019 Feb 1;25(3):1063-1069. doi: 10.1158/1078-0432.CCR-18-1102. Epub 2018 Jul 25.

PMID:
30045933
30.

Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.

Drilon A, Lin JJ, Filleron T, Ni A, Milia J, Bergagnini I, Hatzoglou V, Velcheti V, Offin M, Li B, Carbone DP, Besse B, Mok T, Awad MM, Wolf J, Owen D, Camidge DR, Riely GJ, Peled N, Kris MG, Mazieres J, Gainor JF, Gautschi O.

J Thorac Oncol. 2018 Oct;13(10):1595-1601. doi: 10.1016/j.jtho.2018.07.004. Epub 2018 Jul 11.

PMID:
30017832
31.

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Santini FC, Rizvi H, Plodkowski AJ, Ni A, Lacouture ME, Gambarin-Gelwan M, Wilkins O, Panora E, Halpenny DF, Long NM, Kris MG, Rudin CM, Chaft JE, Hellmann MD.

Cancer Immunol Res. 2018 Sep;6(9):1093-1099. doi: 10.1158/2326-6066.CIR-17-0755. Epub 2018 Jul 10.

PMID:
29991499
32.

Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.

Li BT, Shen R, Buonocore D, Olah ZT, Ni A, Ginsberg MS, Ulaner GA, Offin M, Feldman D, Hembrough T, Cecchi F, Schwartz S, Pavlakis N, Clarke S, Won HH, Brzostowski EB, Riely GJ, Solit DB, Hyman DM, Drilon A, Rudin CM, Berger MF, Baselga J, Scaltriti M, Arcila ME, Kris MG.

J Clin Oncol. 2018 Aug 20;36(24):2532-2537. doi: 10.1200/JCO.2018.77.9777. Epub 2018 Jul 10. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):362.

33.

Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant.

Vardhana S, Hamlin PA, Yang J, Zelenetz A, Sauter CS, Matasar MJ, Ni A, Yahalom J, Moskowitz CH.

Biol Blood Marrow Transplant. 2018 Oct;24(10):2133-2138. doi: 10.1016/j.bbmt.2018.06.009. Epub 2018 Jun 15.

PMID:
29909154
34.

Toward a panoramic perspective of the association between environmental factors and cardiovascular disease: An environment-wide association study from National Health and Nutrition Examination Survey 1999-2014.

Zhuang X, Guo Y, Ni A, Yang D, Liao L, Zhang S, Zhou H, Sun X, Wang L, Wang X, Liao X.

Environ Int. 2018 Sep;118:146-153. doi: 10.1016/j.envint.2018.05.046. Epub 2018 Jun 4.

PMID:
29879615
35.

Cognition as a Window into Neuronal Population Space.

Ruff DA, Ni AM, Cohen MR.

Annu Rev Neurosci. 2018 Jul 8;41:77-97. doi: 10.1146/annurev-neuro-080317-061936.

PMID:
29799773
36.

The neural signatures of egocentric bias in normative decision-making.

Feng C, Feng X, Wang L, Wang L, Gu R, Ni A, Deshpande G, Li Z, Luo YJ.

Brain Imaging Behav. 2018 May 16. doi: 10.1007/s11682-018-9893-1. [Epub ahead of print]

PMID:
29767303
37.

Ketamine exposure demographics and outcomes over 16 years as reported to US poison centers.

Ni A, Lee Cantrell F, Clark RF.

Am J Emerg Med. 2018 Aug;36(8):1459-1462. doi: 10.1016/j.ajem.2018.04.066. Epub 2018 May 3.

PMID:
29754964
38.

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Hellmann MD, Nathanson T, Rizvi H, Creelan BC, Sanchez-Vega F, Ahuja A, Ni A, Novik JB, Mangarin LMB, Abu-Akeel M, Liu C, Sauter JL, Rekhtman N, Chang E, Callahan MK, Chaft JE, Voss MH, Tenet M, Li XM, Covello K, Renninger A, Vitazka P, Geese WJ, Borghaei H, Rudin CM, Antonia SJ, Swanton C, Hammerbacher J, Merghoub T, McGranahan N, Snyder A, Wolchok JD.

Cancer Cell. 2018 May 14;33(5):843-852.e4. doi: 10.1016/j.ccell.2018.03.018. Epub 2018 Apr 12.

39.

Genome-wide detection of CNVs associated with beak deformity in chickens using high-density 600K SNP arrays.

Bai H, Sun Y, Liu N, Liu Y, Xue F, Li Y, Xu S, Ni A, Ye J, Chen Y, Chen J.

Anim Genet. 2018 Jun;49(3):226-236. doi: 10.1111/age.12652. Epub 2018 Apr 11.

PMID:
29642269
40.

An organic-inorganic hybrid zinc phosphite framework with room temperature phosphorescence.

Ni AY, Mu Y, Pan J, Han SD, Shang MM, Wang GM.

Chem Commun (Camb). 2018 Apr 10;54(30):3712-3714. doi: 10.1039/c8cc00724a.

PMID:
29578228
41.

Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance.

Yu HA, Suzawa K, Jordan E, Zehir A, Ni A, Kim R, Kris MG, Hellmann MD, Li BT, Somwar R, Solit DB, Berger MF, Arcila M, Riely GJ, Ladanyi M.

Clin Cancer Res. 2018 Jul 1;24(13):3108-3118. doi: 10.1158/1078-0432.CCR-17-2961. Epub 2018 Mar 12.

PMID:
29530932
42.

The second conserved motif in bacterial laccase regulates catalysis and robustness.

Jin L, Yang X, Sheng Y, Cao H, Ni A, Zhang Y.

Appl Microbiol Biotechnol. 2018 May;102(9):4039-4048. doi: 10.1007/s00253-018-8863-2. Epub 2018 Mar 7.

PMID:
29516145
43.

Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.

Cui J, Yan W, Xu S, Wang Q, Zhang W, Liu W, Ni A.

PLoS One. 2018 Mar 1;13(3):e0193171. doi: 10.1371/journal.pone.0193171. eCollection 2018.

44.

Learning and attention reveal a general relationship between population activity and behavior.

Ni AM, Ruff DA, Alberts JJ, Symmonds J, Cohen MR.

Science. 2018 Jan 26;359(6374):463-465. doi: 10.1126/science.aao0284.

PMID:
29371470
45.

Environment-wide association study to identify novel factors associated with peripheral arterial disease: Evidence from the National Health and Nutrition Examination Survey (1999-2004).

Zhuang X, Ni A, Liao L, Guo Y, Dai W, Jiang Y, Zhou H, Hu X, Du Z, Wang X, Liao X.

Atherosclerosis. 2018 Feb;269:172-177. doi: 10.1016/j.atherosclerosis.2018.01.006. Epub 2018 Jan 12.

PMID:
29366990
46.

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

Rizvi H, Sanchez-Vega F, La K, Chatila W, Jonsson P, Halpenny D, Plodkowski A, Long N, Sauter JL, Rekhtman N, Hollmann T, Schalper KA, Gainor JF, Shen R, Ni A, Arbour KC, Merghoub T, Wolchok J, Snyder A, Chaft JE, Kris MG, Rudin CM, Socci ND, Berger MF, Taylor BS, Zehir A, Solit DB, Arcila ME, Ladanyi M, Riely GJ, Schultz N, Hellmann MD.

J Clin Oncol. 2018 Mar 1;36(7):633-641. doi: 10.1200/JCO.2017.75.3384. Epub 2018 Jan 16.

47.

The Effects of a Macromolecular Charring Agent with Gas Phase and Condense Phase Synergistic Flame Retardant Capability on the Properties of PP/IFR Composites.

Chen H, Wang J, Ni A, Ding A, Han X, Sun Z.

Materials (Basel). 2018 Jan 11;11(1). pii: E111. doi: 10.3390/ma11010111.

48.

Alteration of glucocorticoid receptors and exacerbation of inflammation during lytic cytomegalovirus infection in THP-1 cells.

Wang S, Dou Y, Yang H, Ni A, Zhang R, Qian J.

FEBS Open Bio. 2017 Oct 30;7(12):1924-1931. doi: 10.1002/2211-5463.12334. eCollection 2017 Dec.

49.

Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non-Small Cell Lung Cancer.

Arbour KC, Jordan E, Kim HR, Dienstag J, Yu HA, Sanchez-Vega F, Lito P, Berger M, Solit DB, Hellmann M, Kris MG, Rudin CM, Ni A, Arcila M, Ladanyi M, Riely GJ.

Clin Cancer Res. 2018 Jan 15;24(2):334-340. doi: 10.1158/1078-0432.CCR-17-1841. Epub 2017 Oct 31.

50.

Novel histone deacetylase inhibitor N25 exerts anti-tumor effects and induces autophagy in human glioma cells by inhibiting HDAC3.

Sun XY, Qu Y, Ni AR, Wang GX, Huang WB, Chen ZP, Lv ZF, Zhang S, Lindsay H, Zhao S, Li XN, Feng BH.

Oncotarget. 2017 Sep 8;8(43):75232-75242. doi: 10.18632/oncotarget.20744. eCollection 2017 Sep 26.

Supplemental Content

Support Center